Other
Hemostasis
0
Pipeline Programs↗
5
Active Trials↗
1
Companies Involved↗
Hemostasis is an early-stage landscape with 0 programs across 1 company. The most active players are Bayer.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
13
clinical trials
Completed7 · 54%
Recruiting4 · 31%
Unknown status1 · 8%
Not yet recruiting1 · 8%
Clinical Trials
Trial Activity
13 trials
Development of a Device for Evaluating Primary Hemostasis Under Whole Blood Flow Conditions
Recruiting·—·N/A·NCT03773159·200 enrolled
Safe and Fast Radial Hemostasis Using Synergistic Strategies: SAFE & FAST Trial
Completed·—·N/A·NCT06549842·451 enrolled
Comparison of A-PRF vs Bone Wax in Hemostasis, Pain Relief and Healing Following Exodontia
Unknown status·—·N/A·NCT05744726·129 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)